Put PDE5 Inhibitor Risks in Perspective
June 2022
More data linking PDE5 inhibitors (sildenafil, etc) to eye problems will raise questions about safety.
Labels already warn of rare optic neuropathy...which can cause loss of vision that may be permanent.
New evidence suggests that this and other serious eye conditions (retinal detachment, etc) occur in about 16 in 10,000 patients per year on a PDE5 inhibitor...higher than prior estimates.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote